OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications
Publication Date
June 21, 2016
Journal
PLOS ONE
Authors
Ruwen Böhm, Leocadie Von Hehn, Thomas Herdegen, Hans Joachim Klein, et al
Volume
11
Issue
6
Pages
e0157753
DOI
http://doi.org/10.1371/journal.pone.0157753
Publisher URL
http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0157753
Web of Science
000378212400038
Scopus
84976583609
Mendeley
http://www.mendeley.com/research/openvigil-fda-inspection-american-adverse-drug-events-pharmacovigilance-data-novel-clinical-applicat
Events
Loading … Spinner

Mendeley | Further Information

{"title"=>"OpenVigil FDA - Inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications", "type"=>"journal", "authors"=>[{"first_name"=>"Ruwen", "last_name"=>"B??hm", "scopus_author_id"=>"34869133800"}, {"first_name"=>"Leocadie", "last_name"=>"Von Hehn", "scopus_author_id"=>"57190028626"}, {"first_name"=>"Thomas", "last_name"=>"Herdegen", "scopus_author_id"=>"7004680390"}, {"first_name"=>"Hans Joachim", "last_name"=>"Klein", "scopus_author_id"=>"57190025656"}, {"first_name"=>"Oliver", "last_name"=>"Bruhn", "scopus_author_id"=>"22333446300"}, {"first_name"=>"Holger", "last_name"=>"Petri", "scopus_author_id"=>"57190021899"}, {"first_name"=>"Jan", "last_name"=>"H??cker", "scopus_author_id"=>"55028200200"}], "year"=>2016, "source"=>"PLoS ONE", "identifiers"=>{"doi"=>"10.1371/journal.pone.0157753", "pui"=>"610977322", "pmid"=>"27326858", "sgr"=>"84976583609", "scopus"=>"2-s2.0-84976583609", "issn"=>"19326203"}, "id"=>"1000647f-f481-34f7-b7f1-20063f5ac8bf", "abstract"=>"Pharmacovigilance contributes to health care. However, direct access to the underlying data for academic institutions and individual physicians or pharmacists is intricate, and easily employable analysis modes for everyday clinical situations are missing. This underlines the need for a tool to bring pharmacovigilance to the clinics. To address these issues, we have developed OpenVigil FDA, a novel web-based pharmacovigilance analysis tool which uses the openFDA online interface of the Food and Drug Administration (FDA) to access U.S. American and international pharmacovigilance data from the Adverse Event Reporting System (AERS). OpenVigil FDA provides disproportionality analyses to (i) identify the drug most likely evoking a new adverse event, (ii) compare two drugs concerning their safety profile, (iii) check arbitrary combinations of two drugs for unknown drug-drug interactions and (iv) enhance the relevance of results by identifying confounding factors and eliminating them using background correction. We present examples for these applications and discuss the promises and limits of pharmacovigilance, openFDA and OpenVigil FDA. OpenVigil FDA is the first public available tool to apply pharmacovigilance findings directly to real-life clinical problems. OpenVigil FDA does not require special licenses or statistical programs.", "link"=>"http://www.mendeley.com/research/openvigil-fda-inspection-american-adverse-drug-events-pharmacovigilance-data-novel-clinical-applicat", "reader_count"=>14, "reader_count_by_academic_status"=>{"Student > Doctoral Student"=>1, "Student > Ph. D. Student"=>4, "Student > Master"=>5, "Professor"=>1, "Student > Bachelor"=>3}, "reader_count_by_user_role"=>{"Student > Doctoral Student"=>1, "Student > Ph. D. Student"=>4, "Student > Master"=>5, "Professor"=>1, "Student > Bachelor"=>3}, "reader_count_by_subject_area"=>{"Agricultural and Biological Sciences"=>2, "Medicine and Dentistry"=>11, "Pharmacology, Toxicology and Pharmaceutical Science"=>1}, "reader_count_by_subdiscipline"=>{"Medicine and Dentistry"=>{"Medicine and Dentistry"=>11}, "Agricultural and Biological Sciences"=>{"Agricultural and Biological Sciences"=>2}, "Pharmacology, Toxicology and Pharmaceutical Science"=>{"Pharmacology, Toxicology and Pharmaceutical Science"=>1}}, "group_count"=>2}

Scopus | Further Information

{"@_fa"=>"true", "link"=>[{"@_fa"=>"true", "@ref"=>"self", "@href"=>"https://api.elsevier.com/content/abstract/scopus_id/84976583609"}, {"@_fa"=>"true", "@ref"=>"author-affiliation", "@href"=>"https://api.elsevier.com/content/abstract/scopus_id/84976583609?field=author,affiliation"}, {"@_fa"=>"true", "@ref"=>"scopus", "@href"=>"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84976583609&origin=inward"}, {"@_fa"=>"true", "@ref"=>"scopus-citedby", "@href"=>"https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84976583609&origin=inward"}], "prism:url"=>"https://api.elsevier.com/content/abstract/scopus_id/84976583609", "dc:identifier"=>"SCOPUS_ID:84976583609", "eid"=>"2-s2.0-84976583609", "dc:title"=>"OpenVigil FDA - Inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications", "dc:creator"=>"Böhm R.", "prism:publicationName"=>"PLoS ONE", "prism:eIssn"=>"19326203", "prism:volume"=>"11", "prism:issueIdentifier"=>"6", "prism:pageRange"=>nil, "prism:coverDate"=>"2016-06-01", "prism:coverDisplayDate"=>"June 2016", "prism:doi"=>"10.1371/journal.pone.0157753", "citedby-count"=>"2", "affiliation"=>[{"@_fa"=>"true", "affilname"=>"Universitatsklinikum Schleswig-Holstein Campus Kiel", "affiliation-city"=>"Kiel", "affiliation-country"=>"Germany"}], "prism:aggregationType"=>"Journal", "subtype"=>"ar", "subtypeDescription"=>"Article", "article-number"=>"e0157753", "source-id"=>"10600153309"}

Facebook

  • {"url"=>"http%3A%2F%2Fjournals.plos.org%2Fplosone%2Farticle%3Fid%3D10.1371%252Fjournal.pone.0157753", "share_count"=>2, "like_count"=>0, "comment_count"=>0, "click_count"=>0, "total_count"=>2}

Counter

  • {"month"=>"6", "year"=>"2016", "pdf_views"=>"35", "xml_views"=>"0", "html_views"=>"267"}
  • {"month"=>"7", "year"=>"2016", "pdf_views"=>"60", "xml_views"=>"0", "html_views"=>"155"}
  • {"month"=>"8", "year"=>"2016", "pdf_views"=>"42", "xml_views"=>"0", "html_views"=>"103"}
  • {"month"=>"9", "year"=>"2016", "pdf_views"=>"25", "xml_views"=>"0", "html_views"=>"86"}
  • {"month"=>"10", "year"=>"2016", "pdf_views"=>"16", "xml_views"=>"0", "html_views"=>"71"}
  • {"month"=>"11", "year"=>"2016", "pdf_views"=>"16", "xml_views"=>"0", "html_views"=>"99"}
  • {"month"=>"12", "year"=>"2016", "pdf_views"=>"0", "xml_views"=>"0", "html_views"=>"99"}
  • {"month"=>"1", "year"=>"2017", "pdf_views"=>"23", "xml_views"=>"4", "html_views"=>"83"}
  • {"month"=>"2", "year"=>"2017", "pdf_views"=>"19", "xml_views"=>"4", "html_views"=>"126"}
  • {"month"=>"3", "year"=>"2017", "pdf_views"=>"16", "xml_views"=>"3", "html_views"=>"83"}

PMC Usage Stats

  • {"unique-ip"=>"15", "full-text"=>"14", "pdf"=>"3", "abstract"=>"0", "scanned-summary"=>"0", "scanned-page-browse"=>"0", "figure"=>"10", "supp-data"=>"1", "cited-by"=>"0", "year"=>"2016", "month"=>"7"}
  • {"unique-ip"=>"22", "full-text"=>"24", "pdf"=>"6", "abstract"=>"0", "scanned-summary"=>"0", "scanned-page-browse"=>"0", "figure"=>"2", "supp-data"=>"0", "cited-by"=>"0", "year"=>"2016", "month"=>"9"}
  • {"unique-ip"=>"16", "full-text"=>"16", "pdf"=>"5", "abstract"=>"0", "scanned-summary"=>"0", "scanned-page-browse"=>"0", "figure"=>"1", "supp-data"=>"0", "cited-by"=>"0", "year"=>"2016", "month"=>"10"}
  • {"unique-ip"=>"19", "full-text"=>"24", "pdf"=>"2", "abstract"=>"0", "scanned-summary"=>"0", "scanned-page-browse"=>"0", "figure"=>"9", "supp-data"=>"0", "cited-by"=>"0", "year"=>"2016", "month"=>"11"}
  • {"unique-ip"=>"20", "full-text"=>"17", "pdf"=>"4", "abstract"=>"0", "scanned-summary"=>"0", "scanned-page-browse"=>"0", "figure"=>"5", "supp-data"=>"0", "cited-by"=>"0", "year"=>"2017", "month"=>"1"}
Loading … Spinner
There are currently no alerts